Sight Sciences, Inc. (SGHT)
Sight Sciences, Inc. (SGHT) from its SEC filings: 2025 revenue $77.4 million (-3% vs the year before), net margin -50%, free cash flow -$29.9 million. Insider trades, recent filings and a price chart. Free.
| Exchange | Nasdaq |
| Industry | Surgical & Medical Instruments & Apparatus |
| Revenue (2025) | $77.4 million |
| Revenue growth | -3% |
| Net income | -$38.4 million |
| Net margin | -49.7% |
| Free cash flow | -$29.9 million |
| Diluted EPS | $-0.74 |
| Latest quarter (Q3 2026 (calendar)) revenue vs a year earlier | +25% |
| Cash | $77.4 million |
| Long-term debt | $35.0 million |
| Share count, 1 year | +5% |
| Fundamentals check | Weak fundamentals |
Source: SEC EDGAR company filings (XBRL), updated 2026-11-08. Education only, not financial advice.